Using silkworms as a laboratory animal to evaluate medicines and foods.

Sekimizu K, Hamamoto H

Drug Discov Ther. 2016; 10(1):1-2.

DOI: 10.5582/ddt.2016.01018

Summary Full Text (PDF)

Can the silkworm (Bombyx mori) be used as a human disease model?

Tabunoki H, Bono H, Ito K, Yokoyama T

Drug Discov Ther. 2016; 10(1):3-8.

DOI: 10.5582/ddt.2016.01011

Summary Full Text (PDF)

Usefulness of silkworm as a host animal for understanding pathogenicity of Cryptococcus neoformans.

Ishii M, Matsumoto Y, Sekimizu K

Drug Discov Ther. 2016; 10(1):9-13.

DOI: 10.5582/ddt.2016.01015

Summary Full Text (PDF)

A hyperglycemic silkworm model for evaluating hypoglycemic activity of Rehmanniae Radix, an herbal medicine.

Matsumoto Y, Sekimizu K

Drug Discov Ther. 2016; 10(1):14-18.

DOI: 10.5582/ddt.2016.01016

Summary Full Text (PDF)

Evaluation of anti-diabetic drugs by using silkworm, Bombyx mori.

Matsumoto Y, Sekimizu K

Drug Discov Ther. 2016; 10(1):19-23.

DOI: 10.5582/ddt.2016.01017

Summary Full Text (PDF)

Identification of lysocin E using a silkworm model of bacterial infection.

Hamamoto H, Sekimizu K

Drug Discov Ther. 2016; 10(1):24-29.

DOI: 10.5582/ddt.2016.01012

Summary Full Text (PDF)

Understanding of bacterial virulence using the silkworm infection model.

Kaito C

Drug Discov Ther. 2016; 10(1):30-33.

DOI: 10.5582/ddt.2016.01020

Summary Full Text (PDF)

Recent progress in development of transgenic silkworms overexpressing recombinant human proteins with therapeutic potential in silk glands.

Itoh K, Kobayashi I, Nishioka S, Sezutsu H, Machii H, Tamura T

Drug Discov Ther. 2016; 10(1):34-39.

DOI: 10.5582/ddt.2016.01024

Summary Full Text (PDF)

Using silkworms to establish alternative animal models for evaluation of drug-induced tissue injury.

Inagaki Y, Matsumoto Y, Sekimizu K

Drug Discov Ther. 2016; 10(1):40-43.

DOI: 10.5582/ddt.2016.01023

Summary Full Text (PDF)

Therapeutic effects of three trichothecenes in the silkworm infection assay with Candida albicans.

Uchida R, Namiguchi S, Ishijima H, Tomoda H

Drug Discov Ther. 2016; 10(1):44-48.

DOI: 10.5582/ddt.2016.01013

Summary Full Text (PDF)

Lactic acid bacteria activating innate immunity improve survival in bacterial infection model of silkworm.

Nishida S, Ono Y, Sekimizu K

Drug Discov Ther. 2016; 10(1):49-56.

DOI: 10.5582/ddt.2016.01022

Summary Full Text (PDF)

Acute oral toxicity test of chemical compounds in silkworms.

Usui K, Nishida S, Sugita T, Ueki T, Matsumoto Y, Okumura H, Sekimizu K

Drug Discov Ther. 2016; 10(1):57-61.

DOI: 10.5582/ddt.2016.01025

Summary Full Text (PDF)